CKD Bio (063160.KS) Stock Price

CKD Bio Price

CLOSED
14,560.00KRW+200.00 (+1.38 %)
Market closed

Revenue has compounded at 5.3% per year over the past 19 years to 171.76 B KRW. Earnings per share have grown at 17.6% per year over the last 18 years. CKD Bio's net margin stands at 5.1%, broadly stable from 5.0% several years earlier. CKD Bio currently offers a dividend yield of about 0.69%. The payout ratio is around 6% of earnings. Analysts set a median price target of 40,362.86 KRW, implying 177.2% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 17% above its 52-week low.

CKD Bio stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of CKD Bio over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how CKD Bio stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing CKD Bio's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

CKD Bio Stock Price History
DateCKD Bio Price
8/11/202614,560.00 KRW
8/10/202614,360.00 KRW
8/7/202613,770.00 KRW
8/6/202613,530.00 KRW
8/5/202613,890.00 KRW
8/4/202613,690.00 KRW
8/3/202613,270.00 KRW
7/31/202612,860.00 KRW
7/30/202612,670.00 KRW
7/29/202612,560.00 KRW
7/28/202613,020.00 KRW
7/27/202613,390.00 KRW
7/24/202613,340.00 KRW
7/23/202613,010.00 KRW
7/22/202612,820.00 KRW
7/21/202612,850.00 KRW
7/20/202613,050.00 KRW
7/16/202613,400.00 KRW
7/15/202613,290.00 KRW
7/14/202613,100.00 KRW
7/13/202613,180.00 KRW
7/10/202613,380.00 KRW
7/9/202612,880.00 KRW
7/8/202613,370.00 KRW
7/7/202613,710.00 KRW
7/6/202613,610.00 KRW
7/3/202613,630.00 KRW
7/2/202613,590.00 KRW
7/1/202613,570.00 KRW
6/30/202613,380.00 KRW
6/29/202613,460.00 KRW
6/26/202612,470.00 KRW
6/25/202613,100.00 KRW
6/24/202613,320.00 KRW
6/23/202613,390.00 KRW
6/22/202614,500.00 KRW
6/19/202615,340.00 KRW
6/18/202615,990.00 KRW
6/17/202616,170.00 KRW
6/16/202616,020.00 KRW
6/15/202615,910.00 KRW
6/12/202615,950.00 KRW
6/11/202615,590.00 KRW
6/10/202615,450.00 KRW
6/9/202615,590.00 KRW
6/8/202615,200.00 KRW
6/5/202615,960.00 KRW
6/4/202616,160.00 KRW
6/2/202616,180.00 KRW
6/1/202616,260.00 KRW
5/29/202616,950.00 KRW
5/28/202617,640.00 KRW
5/27/202617,800.00 KRW
5/26/202617,930.00 KRW
5/22/202617,940.00 KRW
5/21/202617,650.00 KRW
5/20/202617,570.00 KRW
5/19/202617,830.00 KRW
5/18/202618,100.00 KRW
5/15/202618,510.00 KRW
5/14/202618,800.00 KRW
5/13/202618,620.00 KRW
5/12/202618,800.00 KRW
5/11/202618,800.00 KRW
5/8/202619,240.00 KRW
5/7/202619,310.00 KRW
5/6/202619,050.00 KRW
5/4/202619,500.00 KRW
4/30/202619,510.00 KRW
4/29/202619,630.00 KRW
4/28/202619,720.00 KRW
4/27/202619,880.00 KRW
4/24/202619,920.00 KRW
4/23/202619,790.00 KRW
4/22/202619,750.00 KRW
4/21/202619,840.00 KRW
4/20/202619,970.00 KRW
4/17/202620,100.00 KRW
4/16/202619,910.00 KRW
4/15/202619,670.00 KRW
4/14/202619,520.00 KRW
4/13/202618,820.00 KRW
4/10/202618,940.00 KRW
4/9/202618,670.00 KRW
4/8/202618,790.00 KRW
4/7/202618,470.00 KRW
4/6/202618,530.00 KRW
4/3/202618,840.00 KRW
4/2/202618,760.00 KRW
4/1/202619,240.00 KRW
3/31/202618,750.00 KRW
3/30/202619,020.00 KRW
3/27/202619,410.00 KRW
3/26/202619,400.00 KRW
3/25/202619,590.00 KRW
3/24/202618,950.00 KRW
3/23/202618,980.00 KRW
3/20/202619,370.00 KRW
3/19/202619,360.00 KRW
3/18/202619,580.00 KRW
3/17/202619,350.00 KRW
3/16/202619,270.00 KRW
3/13/202619,490.00 KRW
3/12/202619,510.00 KRW
3/11/202619,500.00 KRW
3/10/202619,440.00 KRW
3/9/202619,330.00 KRW
3/6/202619,990.00 KRW
3/5/202619,720.00 KRW
2/26/202621,300.00 KRW
2/25/202621,300.00 KRW
2/24/202621,550.00 KRW
2/23/202621,300.00 KRW
2/20/202621,000.00 KRW
2/19/202621,200.00 KRW
2/13/202621,050.00 KRW
2/12/202621,400.00 KRW
2/11/202621,200.00 KRW
2/10/202621,400.00 KRW
2/9/202621,000.00 KRW
2/6/202620,800.00 KRW
2/5/202621,300.00 KRW
2/4/202621,350.00 KRW
2/3/202621,250.00 KRW
2/2/202620,500.00 KRW
1/30/202621,450.00 KRW
1/29/202621,950.00 KRW
1/28/202621,750.00 KRW
1/27/202621,500.00 KRW
1/26/202621,300.00 KRW
1/23/202621,250.00 KRW
1/22/202621,150.00 KRW
1/21/202621,050.00 KRW
1/20/202622,750.00 KRW
1/19/202619,160.00 KRW
1/16/202619,440.00 KRW
1/15/202619,550.00 KRW
1/14/202619,720.00 KRW
1/13/202619,800.00 KRW
1/12/202619,960.00 KRW
1/9/202620,000.00 KRW
1/8/202620,050.00 KRW
1/7/202620,250.00 KRW
1/6/202620,450.00 KRW
1/5/202620,450.00 KRW
1/2/202620,350.00 KRW
12/30/202520,350.00 KRW
12/29/202520,250.00 KRW
12/26/202520,300.00 KRW
12/24/202520,500.00 KRW
12/23/202520,700.00 KRW
12/22/202520,750.00 KRW
12/19/202520,900.00 KRW
12/18/202520,950.00 KRW
12/17/202521,100.00 KRW
12/16/202521,000.00 KRW
12/15/202520,950.00 KRW
12/12/202521,250.00 KRW
12/11/202521,250.00 KRW
12/10/202521,300.00 KRW
12/9/202521,300.00 KRW
12/8/202521,100.00 KRW
12/5/202521,500.00 KRW
12/4/202521,450.00 KRW
12/3/202521,250.00 KRW
12/2/202521,450.00 KRW
11/28/202521,250.00 KRW
11/27/202521,150.00 KRW
11/26/202520,950.00 KRW
11/25/202520,700.00 KRW
11/24/202521,000.00 KRW
11/21/202521,050.00 KRW
11/20/202521,400.00 KRW
11/19/202521,000.00 KRW
11/18/202521,050.00 KRW
11/17/202521,500.00 KRW
11/14/202521,750.00 KRW
11/13/202521,850.00 KRW
11/12/202521,800.00 KRW
11/11/202520,750.00 KRW
11/10/202521,050.00 KRW
11/7/202520,800.00 KRW
11/6/202521,350.00 KRW
11/5/202520,650.00 KRW
11/4/202520,800.00 KRW
11/3/202520,700.00 KRW
10/31/202521,600.00 KRW
10/30/202521,400.00 KRW
10/29/202521,800.00 KRW
10/28/202521,800.00 KRW
10/27/202521,900.00 KRW
10/24/202521,150.00 KRW
10/23/202521,400.00 KRW
10/22/202521,750.00 KRW
10/21/202521,950.00 KRW
10/20/202522,200.00 KRW
10/17/202522,150.00 KRW
10/16/202522,400.00 KRW
10/15/202522,850.00 KRW
10/14/202522,450.00 KRW
10/13/202522,750.00 KRW
10/10/202523,400.00 KRW
10/2/202523,800.00 KRW
10/1/202523,200.00 KRW
9/30/202522,850.00 KRW
9/29/202523,250.00 KRW
9/26/202522,900.00 KRW
9/25/202523,500.00 KRW
9/24/202523,950.00 KRW
9/23/202524,100.00 KRW
9/22/202524,050.00 KRW
9/19/202524,500.00 KRW
9/18/202523,900.00 KRW
9/17/202523,600.00 KRW
9/16/202523,450.00 KRW
9/15/202523,800.00 KRW
9/12/202523,550.00 KRW
9/11/202523,500.00 KRW
9/10/202523,650.00 KRW
9/9/202523,650.00 KRW
9/8/202523,700.00 KRW
9/5/202523,450.00 KRW
9/4/202523,100.00 KRW
9/3/202523,100.00 KRW
9/2/202522,650.00 KRW
9/1/202522,500.00 KRW
8/29/202522,900.00 KRW
8/28/202522,850.00 KRW
8/27/202522,850.00 KRW
8/26/202523,000.00 KRW
8/25/202522,850.00 KRW
8/22/202522,500.00 KRW
8/21/202522,250.00 KRW
8/20/202522,350.00 KRW
8/19/202522,650.00 KRW
8/18/202522,800.00 KRW
8/14/202522,800.00 KRW
Access this data via the Eulerpool API
Get Free API Key

CKD Bio Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
118.19 B KRW
9.03 B KRW
8.02 B KRW
Jan 1, 2018
124.51 B KRW
7.01 B KRW
7.96 B KRW
Jan 1, 2019
137.18 B KRW
15.41 B KRW
12.27 B KRW
Jan 1, 2020
124.60 B KRW
7.61 B KRW
6.21 B KRW
Jan 1, 2021
142.24 B KRW
-11.43 B KRW
-6.58 B KRW
Jan 1, 2022
156.04 B KRW
-14.81 B KRW
-16.70 B KRW
Jan 1, 2023
160.35 B KRW
-20.15 B KRW
-24.19 B KRW
Jan 1, 2024
171.76 B KRW
10.95 B KRW
8.70 B KRW

CKD Bio Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 14, 2026, 12:44 AM
 
REVENUEB KRW
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB KRW
EBITB KRW
EBIT MARGIN%
NET INCOMEB KRW
NET INCOME GROWTH%
DIV.KRW
DIV. GROWTH%
SHARESM
2009201020112012201320142015201620172018201920202021202220232024
106.55121.57110.53113.76100.37106.39106.69113.01118.19124.51137.18124.60142.24156.04160.35171.76
27.7714.09-9.082.92-11.776.000.285.934.585.3510.18-9.1714.169.702.767.11
27.8026.4321.6120.1414.658.5419.2323.3521.0618.8126.3722.369.3510.765.0020.93
29.6332.1323.8822.9114.709.0920.5226.3924.8923.4236.1727.8613.3116.798.0135.94
17.0919.319.458.801.95-2.648.0411.629.037.0115.417.61-11.43-14.81-20.1510.95
16.0415.888.557.731.94-2.487.5410.287.645.6311.246.11-8.04-9.49-12.576.38
16.1816.5210.927.101.66-1.116.659.448.027.9612.276.21-6.58-16.70-24.198.70
85.212.05-33.88-34.98-76.67-166.69-702.0841.82-15.04-0.7554.16-49.39-205.94153.9844.84-135.96
300.00400.00350.00350.00100.00100.00350.00400.00400.00200.00190.48200.00100.00100.00–100.00
20.0033.33-12.50–-71.43–250.0014.29–-50.00-4.765.00-50.00–––
5.005.005.005.005.005.005.005.005.005.005.005.005.495.495.495.49
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales CKD Bio generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue CKD Bio retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare CKD Bio's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares CKD Bio has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against CKD Bio's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

CKD Bio stock margins

The CKD Bio margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CKD Bio. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CKD Bio.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
21.06 %
7.64 %
6.78 %
Jan 1, 2018
18.81 %
5.63 %
6.39 %
Jan 1, 2019
26.37 %
11.24 %
8.94 %
Jan 1, 2020
22.36 %
6.11 %
4.98 %
Jan 1, 2021
9.35 %
-8.04 %
-4.62 %
Jan 1, 2022
10.76 %
-9.49 %
-10.70 %
Jan 1, 2023
5.00 %
-12.57 %
-15.09 %
Jan 1, 2024
20.93 %
6.38 %
5.07 %

CKD Bio Stock Revenue, EBIT, Earnings per Share

The CKD Bio earnings per share therefore indicates how much revenue CKD Bio has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
23,637.40 KRW
1,806.60 KRW
1,603.20 KRW
Jan 1, 2018
24,902.00 KRW
1,401.80 KRW
1,591.20 KRW
Jan 1, 2019
27,436.80 KRW
3,082.60 KRW
2,453.00 KRW
Jan 1, 2020
24,920.00 KRW
1,521.40 KRW
1,241.40 KRW
Jan 1, 2021
25,927.53 KRW
-2,083.90 KRW
-1,198.80 KRW
Jan 1, 2022
28,443.73 KRW
-2,699.66 KRW
-3,044.59 KRW
Jan 1, 2023
29,229.45 KRW
-3,673.45 KRW
-4,409.86 KRW
Jan 1, 2024
31,308.06 KRW
1,996.64 KRW
1,586.01 KRW

CKD Bio business model & stock analysis

CKD Bio Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

CKD Bio historical P/E ratio, EBIT multiple, and P/S ratio

CKD Bio annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

CKD Bio shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
5.00 M Stocks
Jan 1, 2018
5.00 M Stocks
Jan 1, 2019
5.00 M Stocks
Jan 1, 2020
5.00 M Stocks
Jan 1, 2021
5.49 M Stocks
Jan 1, 2022
5.49 M Stocks
Jan 1, 2023
5.49 M Stocks
Jan 1, 2024
5.49 M Stocks

CKD Bio stock splits

In CKD Bio's history, there have been no stock splits.

CKD Bio Dividend History

17 years of dividend payments

YearAnnual DividendYoY ChangePayments
2024100.00KRW 0.0%1×
2022100.00KRW 0.0%—
2021100.00KRW↓ 50.0%1×
2020200.00KRW↑ 5.0%1×
2019190.48KRW↓ 4.8%1×
2018200.00KRW↓ 50.0%1×
2017400.00KRW 0.0%1×
2016400.00KRW↑ 14.3%1×
2015350.00KRW↑ 250.0%1×
2014100.00KRW 0.0%1×

CKD Bio dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
23.76 %
Jan 1, 2018
11.97 %
Jan 1, 2019
7.77 %
Jan 1, 2020
16.11 %
Jan 1, 2021
-8.34 %
Jan 1, 2022
10.06 %
Jan 1, 2023
10.83 %
Jan 1, 2024
6.31 %

Current CKD Bio forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
85.71 % (6)
Hold
14.29 % (1)
Sell
0.00 % (0)
12M Price Target
40,362.86
Last Price
14,300.00
Currency
KRW
12M Return Potential
182.26 %
LTM Return
0 %

CKD Bio shareholder structure

% Name
0.40587%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.02616%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.
0.02443%
Samsung Asset Management Co., Ltd.
Samsung Asset Management Co., Ltd.
0.01258%
KB Asset Management Co., Ltd.
KB Asset Management Co., Ltd.
0.00897%
Mirae Asset Global Investments Co., Ltd.
Mirae Asset Global Investments Co., Ltd.
0.00529%
Hanwha Asset Management Co., Ltd.
Hanwha Asset Management Co., Ltd.

CKD Bio Beneficial Ownership Filings (SEC 13D/G)

Free Float
62.0%
Float Shares
-
Shares Outstanding
-

CKD Bio Executives and Management Board

6 members · avg. age 58

Management

JL

Joeng Jin Lee (52)

Chief Executive Officer, Director · since 2017

–
SS

Saeng Gyu Seo (55)

Assistant Managing Director · since 2012

–
HH

Hak Yeon Hwang (59)

Assistant Managing Director

–
HL

Hae Mun Lee (57)

Internal Auditor

–
HY

Hae Hun Yoon

IR Contact Officer

–

Board of Directors

GG

Gwang Seop Gil (65)

Non-Executive Independent Director

–

CKD Bio Supply Chain

CKD Bio Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
Croda International
Supplier·Chemicals·GB
0.21
-0.40
0.31
0.76
-0.11
-0.27

Frequently asked questions about CKD Bio

Analysts currently set an average price target of 40,362.86 KRW for the CKD Bio stock (median: 40,362.86 KRW), implying +182.3 % versus the latest price. The consensus is based on 7 analyst ratings.

CKD Bio Analyst Price Targets 2026

5 analysts currently rate the CKD Bio stock: 4 recommend buying, 1 holding and 0 selling.

CKD Bio Analyst Price Targets 2026

Converted at the current exchange rate, the CKD Bio share trades at 8.91 EUR (14,560.00 KRW).

No history available for CKD Bio.

The revenue cannot currently be calculated for CKD Bio.

The profit cannot currently be calculated for CKD Bio.

The P/E ratio cannot be calculated for CKD Bio at the moment.

The P/S cannot be calculated for CKD Bio currently.

The Eulerpool Quality Score for CKD Bio is 3/10.

The ISIN of CKD Bio is KR7063160006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of CKD Bio is 063160.KS. The ticker symbol is used to trade CKD Bio shares on the stock exchange.

Over the past 12 months, CKD Bio paid a dividend of 100.00 KRW . This corresponds to a dividend yield of about 0.69 %. For the coming 12 months, CKD Bio is expected to pay a dividend of 100.00 KRW.

The current dividend yield of CKD Bio is 0.69 %.

CKD Bio pays a dividend, distributed in the months of , , , .

CKD Bio paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 100.00 KRW are expected. This corresponds to a dividend yield of 0.69 %.

CKD Bio is assigned to the 'Health' sector.

To receive the latest dividend of CKD Bio from amounting to 100 KRW, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, CKD Bio distributed 100 KRW as dividends.

The dividends of CKD Bio are distributed in KRW.

All fundamentals and in-depth analysis of CKD Bio

Our stock analysis for CKD Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CKD Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

CKD Bio Stock
CKD Bio Revenue→
CKD Bio Stock
CKD Bio Net Income→
CKD Bio Stock
CKD Bio P/E→
CKD Bio Stock
CKD Bio P/S→
CKD Bio Stock
CKD Bio EBIT→
CKD Bio Stock
CKD Bio Dividend→
CKD Bio Stock
CKD Bio Directors Dealings→
CKD Bio Stock
CKD Bio Stocks→
CKD Bio Stock
CKD Bio Market capitalization→
CKD Bio Stock
CKD Bio Debt→
CKD Bio Stock
CKD Bio Liabilities→
CKD Bio Stock
CKD Bio Equity→
CKD Bio Stock
CKD Bio AAQS→
CKD Bio Stock
CKD Bio Employees→
CKD Bio Stock
CKD Bio ROE→
CKD Bio Stock
CKD Bio ROA→
CKD Bio Stock
CKD Bio ROCE→
CKD Bio Stock
CKD Bio News→
CKD Bio Stock
CKD Bio Analyst Price Targets→

Health Stocks

Clal Biotechnology IndustriesCJ BioscienceClarianeCizzle Biotechnology HoldingsClaritevCity View Green HoldingsClarity Medical Group HoldingCitius PharmaceuticalsClarity PharmaceuticalsCitius OncologyClassysCisen Pharmaceutical CoAll Stocks A–Z →